Revision history of "High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial" (Q45048847)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

28 January 2024

  • curprev 13:5313:53, 28 January 2024 KrBot talk contribs 35,514 bytes −1 Set a claim value: title (P1476): High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial undo
  • curprev 13:5313:53, 28 January 2024 KrBot talk contribs 35,515 bytes −1 Changed Dutch label: High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial undo (restore)
  • curprev 13:5313:53, 28 January 2024 KrBot talk contribs 35,516 bytes −1 Changed English label: High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial undo (restore)

22 March 2023

20 April 2022

9 July 2020

29 December 2019

17 July 2019

29 March 2019

11 January 2019

23 December 2018

6 November 2018

9 December 2017

8 December 2017